Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
9.50
-0.03 (-0.31%)
At close: Sep 11, 2026, 4:00 PM EDT
9.71
+0.21 (2.21%)
After-hours: Sep 11, 2026, 4:29 PM EDT
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
102.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 14.22M |
| Coya Therapeutics | 8.02M |
| Atara Biotherapeutics | 6.19M |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
ACET News
- 9 days ago - Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 10 days ago - Adicet Bio completes last patient visit for analysis of prula-cel in lupus - TheFly
- 10 days ago - Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update - Business Wire
- 10 days ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Adicet Bio announces FDA clearance of IND application for ADI-212 - TheFly
- 15 days ago - Adicet Bio Announces FDA Clearance of IND Application for ADI-212 - Business Wire
- 4 weeks ago - Adicet Bio Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - Adicet Bio price target lowered to $90 from $100 at Guggenheim - TheFly